About this trial
The goal of this clinical trials is to learn about the effect of taking Prodentis on a long term basis following periodontal therapy. The main question it aims to answer is
1\. what is the effect of long-term consumption of Prodentis on regulating periodontal health and systemic immune-response, when compare to only taking it for 3 months post RSD?
Eligibility criteria
Qualifiers
The subject has given their written consent to participate in the trial.
All subjects must be aged >18 years old, not pregnant, and presented with number of teeth > 12
Diagnosis for periodontitis Stage III and IV, will be according to 2017 the American Academy of Periodontology (AAP) and European Federation of Periodontology (EFP) classification
Has had 1 round of periodontal therapy within 3-6 months' time from recruitment date, and currently presented with at least 4 residual pockets with pocket depth 5mm and above.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Prodentis